CD274 and neoplasm: Our study also demonstrated a mild correlation between GEP score and PD‐L1 CPS score (r = 0.36), comparable to that reported in the KEYNOTE‐028 study patients with multiple tumor types treated with pembrolizumab, which found a moderate but significant correlation (r = 0.40; p < 0.001; n = 151).15